PHR Phreesia, Inc.
Healthcare$8.92+1.59%ClosedMarket Cap: $551.0M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.58
P/S
1.15
EV/EBITDA
19.67
DCF Value
$50.12
FCF Yield
11.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
61.3%
Operating Margin
-1.4%
Net Margin
0.5%
ROE
0.7%
ROA
0.3%
ROIC
0.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $127.1M | 43.0% | $-5.6M | $1.3M | $— | — |
| FY null | $480.6M | 61.3% | $2.6M | $2.3M | $— | — |
| Q3 null | $120.3M | 68.4% | $3.7M | $4.3M | $— | — |
| Q2 null | $117.3M | 67.9% | $-1.5M | $654.0K | $— | — |
| Q1 null | $115.9M | 67.2% | $-3.3M | $-3.9M | $— | — |
| Q4 null | $109.7M | 69.4% | $-7.6M | $-6.4M | $— | — |
| FY null | $419.8M | 67.9% | $-58.1M | $-58.5M | $— | — |
| Q3 null | $106.8M | 67.7% | $-13.8M | $-14.4M | $— | — |
| Q2 null | $102.1M | 67.9% | $-17.2M | $-18.0M | $— | — |
| Q1 null | $101.2M | 66.4% | $-19.4M | $-19.7M | $— | — |
| Q4 2024 | $95.0M | 66.6% | $-29.6M | $-30.6M | $-0.56 | — |
| FY null | $356.3M | 65.2% | $-136.5M | $-136.9M | $— | — |